2026 Q2 Portfolio Activity
In 2026 Q2, Pivotal bioVenture Partners Investment Advisor LLC maintained a portfolio of 14 distinct positions. The most significant new addition was AVALYN PHARMACEUTICALS INC, now representing 10.34% of the total fund value. They heavily accumulated shares in TREVI THERAPEUTICS INC, increasing the position by 12.2%.
Position History
hover any row below to update
Loading…
Pivotal bioVenture Partners Investment Advisor LLC
San Francisco, CA
Hedge Fund / Life Sciences Specialist
AUM $308M
Total Positions
14
Quarter
2026 Q2
Top Holding
PCVX (26.9%)
Top 10 Concentration
95.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-14 of 14
Pivotal bioVenture Partners Investment Advisor LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PCVX
VAXCYTE INC
|
Healthcare | 26.92% | 28.51% |
#1
Prev: #1
|
6.5 |
—
|
53,045 | 3.9% |
P
S
|
1,425,470 | $82,862,571 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 10.78% | 11.42% |
#2
2
Prev: #4
|
6.0 |
—
|
-90,609 | -6.7% |
P
S
|
1,265,283 | $33,175,720 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 10.56% | 6.63% |
#3
2
Prev: #5
|
7.0 |
—
|
188,946 | 12.2% |
P
S
|
1,742,672 | $32,500,833 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AVLN
AVALYN PHARMACE...
|
Healthcare | 10.34% | — |
#4
Prev: #—
|
8.0 |
—
|
966,792 | — |
NEW
|
966,792 | $31,826,793 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 8.32% | 15.83% |
#5
2
Prev: #3
|
4.8 |
—
|
no change | no change |
P
S
|
1,926,943 | $25,609,072 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 7.12% | 4.44% |
#6
1
Prev: #7
|
3.3 |
—
|
-1 | -0.0% |
P
S
|
611,446 | $21,914,225 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 6.79% | 15.97% |
#7
5
Prev: #2
|
3.2 |
—
|
-174,033 | -10.4% |
P
S
|
1,506,250 | $20,891,688 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 5.20% | 4.08% |
#8
1
Prev: #9
|
3.1 |
—
|
no change | no change |
P
S
|
653,374 | $16,014,197 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 5.04% | 5.73% |
#9
3
Prev: #6
|
3.0 |
—
|
no change | no change |
P
S
|
732,512 | $15,521,929 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 4.05% | 4.14% |
#10
2
Prev: #8
|
2.1 |
—
|
-101,225 | -17.1% |
P
S
|
490,766 | $12,455,641 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 2.61% | 1.58% |
#11
1
Prev: #10
|
3.5 |
—
|
138,100 | 46.7% |
P
S
|
434,033 | $8,020,930 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RLYB
RALLYBIO CORP
|
Healthcare | 1.56% | 0.96% |
#12
1
Prev: #11
|
1.6 |
—
|
no change | no change |
P
S
|
300,579 | $4,809,264 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RXRX
RECURSION PHARM...
|
Healthcare | 0.71% | 0.65% |
#13
1
Prev: #12
|
1.3 |
—
|
no change | no change |
P
S
|
595,518 | $2,185,551 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.00% | 0.06% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-42,581 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-14 of 14 holdings